Parkinson's Disease

CNS Diseases

Parkinson's Disease is the second most common neurodegenerative disease, affecting patients in a range of ages. With no cure yet, Julius Clinical is dedicated to advancing Parkinson's Disease research, addressing the unique challenges through pioneering clinical trials and collaborative networks.

With a patient-centric approach, and an in-house neurologist with experience within Parkinson’s Disease studies, we aim to provide innovative solutions and improve the lives of those affected. Join us in the pursuit of groundbreaking discoveries, accelerating progress, and enhancing treatment options for individuals living with Parkinson’s Disease. 

Meet our scientific leader for Parkinson's Disease

Prof. dr. Teus van Laar is Professor of Neurology, Advanced treatment of Parkinson’s Disease, at the UMC Groningen. He is an experienced clinical trialist. In addition he is Director of Parkinon’s Disease Platform Northern Netherlands, Board member of the Dutch Parkinson Scientists and Vice-chair of the Scientific Advisory Board of Parkinson NL.

Meet our scientific leader for Parkinson's Disease

Prif. Fabrizio Stocchi is a Full Professor of Neurology and Director of the Parkinson’s Disease and Movement Disorders Research Center at IRCCS San Raffaele Rome and University “La Sapienza.” Prof. Stocchi’s research focuses on neuropharmacology for movement disorders and neurodegenerative diseases, resulting in numerous publications on Parkinson’s disease. He is also the Scientific Advisor for the Institute for Parkinson’s Disease Research in Vicenza and is a member of several prestigious neurological societies.

Brain Clinical is Julius Clinical’s proprietary network for CNS clinical trials. This network, which covers 13 countries, includes highly experienced and devoted researchers who specialize in streamlined and rigorously executed clinical trials for Parkinson’s Disease treatments.

We’re proud partner of

We work closely with the Brain Research Center in the Netherlands, which specialises in high-quality clinical trial execution for the indications dementia and Parkinson’s Disease.

Read more

Expert team

Conducting intricate clinical studies in Parkinson’s Disease demands a unique blend of scientific acumen and operational precision. At Julius Clinical, we assemble a dedicated team with specialized expertise to navigate the intricacies of Parkinson’s Disease research standards and to effectively orchestrate clinical trials in this dynamic field.

Lieza exalto

Related webinars

Webinar: Real-World Data in ALS

On 30 May, we hosted the webinar "Real-World Data in ALS", in which we explored the innovative integration of Real World Data (RWD) in clinical trials for Amyotrophic Lateral Sclerosis (ALS). As a critical step forward in the pursuit of effective ...

More webinars

Parkinson's Disease scientific insights

Explore our Parkinson's Disease trial capabilities, case studies, and other resources.

Download

"*" indicates required fields

*
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Request for proposal

"*" indicates required fields

*
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
This field is for validation purposes and should be left unchanged.

Share

Twitter Facebook LinkedIn